CORE
🇺🇦Â
 make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Filters
1 research outputs found
Cost-utility analysis of adjuvant trastuzumab therapy for HER2-positive early-stage breast cancer in the Philippines
Author
A Riewpaiboon
ACHM Wolff
+56Â more
AGO Pichon-Riviere
AHM Aboutorabi
AJM Genuino
AMI Macedo
Ammarin Thakkinstian
Anna Melissa Guerrero
Anne Julienne Genuino
Authority PS
AVM-LM Laudico
AWTR Kurian
Bank TW
Bureau DP-DPaC
CABK Parise
CRD Skedgel
D Gajria
DEW Slamon
DHP-P Division
DP-GM Cameron
DP-P Division
EARE Perez
EARE PĂ©rez
EHJJ Romond
EKS Senkus
Force PSoMO-CPT
Force PSoMO-CPT
Group DBCCPGTW
Group TWB
HBP Joensuu
HCCH Lang
HK-LP Joensuu
HTK Dokainish
ICJ Van Vlaenderen
IM Fund
JAVC BuendĂa
JQ Wong
KJST Dedes
LORS Hedden
LP Garrison Jr
MLKL Kwan
MRH Spielmann
Network. NCC
NLMM Liberato
NQNHV Anh
Organization WH
PC Society
PHI Corporation
Philippines BSnPCBot
Philippines DoH-NBCCP
PPBK Advani
PSHC Hall
R Kongbutr
TFT Shiroiwa
Thanyanan Reungwetwattana
Usa Chaikledkaew
WJZ Chen
WKG Leung
Publication venue
'Springer Science and Business Media LLC'
Publication date
Field of study
No full text
Crossref